Combination Chemotherapy With or Without Monoclonal Antibody Therapy in Treating Patients With Refractory or Relapsed Acute Myelogenous Leukemia

NCT00006045 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

INDUSTRY

Sponsor class

Conditions

Leukemia

Interventions

BIOLOGICAL: lintuzumab
DRUG: cytarabine
DRUG: etoposide
DRUG: mitoxantrone hydrochloride

Sponsor

Facet Biotech

Collaborators

[object Object]